Thank you for your interest in the COVID-PR.
The COVID-PR is currently unavailable in your country.
If you have any questions, please contact us at email@example.com.
Be Part of a Community Working to Advance Medical Innovation in Pregnancy
If you contracted COVID-19 while pregnant and had to seek medical attention to treat it, we need you. By telling us about your experience through short monthly surveys, you’ll be at the forefront of progressing scientific breakthroughs for women, people, and children across the globe.
Are you 18 years of age or older?1/5
Are you pregnant or recently pregnant (pregnancy concluded within the last 30 days)?2/5
Were you treated for COVID-19 during pregnancy or within 90 days before pregnancy?3/5
Have you received at least one treatment of any of the following COVID-19 medications during pregnancy (or within 90 days before pregnancy)?4/5
- Veklury (remdesiver) by Gilead
- Xevudy (sotrovimab) by Glaxosmithkline
- Regen-Cov (casirivimab with imdevimab) by Regeneron
- Lagevrio (molnupiravir) by Merck
To participate in this study, you will be invited to complete one survey during each month of your pregnancy. Please see the sample questions below to get an idea of what the 10 minute monthly questionnaire entails.5/5
- On what date were you diagnosed with COVID-19?
- Did you experience any reactions or adverse events within 48 hours after being treated for COVID-19?
- How tall are you without shoes?
Do you agree to complete these monthly surveys?
This study requires participants to be 18 years of age or older. We thank you for your interest.
The protocol of the COVID-PR study requires participants to be pregnant or recently pregnant (pregnancy concluded within the last 30 days) at enrollment. If this is not your case, consider contacting the manufacturer of the medication you used to treat COVID-19 or the government agency that regulates medications in your country (e.g., U.S. FDA, U.K. MHRA, European Medicines Agency, Public Health Agency of Canada).
The COVID-PR has already reached the necessary number of study participants vaccinated with the Pfizer and Moderna COVID-19 vaccines. Consider joining the US-based V-Safe Pregnancy Registry. Alternatively, contact the manufacturer of the vaccine you used or the government agency that regulates vaccines in your country (e.g., U.S. FDA, U.K. MHRA, European Medicines Agency, Public Health Agency of Canada).
Unfortunately, you are not eligible to join the Registry according to the study protocol. However, you can spread the word and share the Registry with others.